Octreotide in relieving gastrointestinal symptoms due to bowel obstruction.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 7505187.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gastrointestinal obstruction is a common problem in advanced malignant disease, but its management remains controversial. In those patients for whom surgery is not appropriate, medical intervention is the only remaining option. We present a series of 14 patients with intestinal obstruction who were managed with subcutaneous injections of octreotide, a somatostatin analogue which reduces the volume of gastrointestinal secretions. Good control of vomiting was achieved in 12 patients, and no major side effects were observed. Octreotide would appear to be a useful drug in this clinical situation.
Medical subject headings
- Intestinal Obstruction
- Neoplasms
- Octreotide
- Vomiting